JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2011, 60(4):159-164

Improving the quality and cost-effectiveness of depression treatment

Liubov Kavaliauskienė1, Rimantas Pečiūra1, Virginija Adomaitienė2, Ruta Masteiková3,*
1 Lithuanian University of Health Sciences, Medical Academy, Faculty of Pharmacy, Department of Drug Technology and Social Pharmacy, Lithuania
2 Lithuanian University of Health Sciences, Medical Academy, Department of Psychiatry, Kaunas, Lithuania
3 University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Pharmacy, Department of Pharmaceutics, Czech Republic

Cost of depression treatment in Lithuania increases depending mainly on depression relapse rates. Depression relapse is in a great extent conditional on the quality of health care after the disease was diagnosed. This study was thus aimed to evaluate the first-time depression treatment and antidepressants use according to three specialists groups opinion. For this purpose 361 pharmacists, 317 family doctors and 280 psychiatrists were interviewed in Lithuania in 2009. The data on depression diagnoses were obtained from the Republic Psychiatric Health Centre. The volume of total depression diagnoses grew up by 12% during the period under study (2004-2009), the amount of relapsed depression diagnoses by 27%. According to family doctors' opinion, 13% of respondents still do not initiate depression treatment by themselves and 62% of them refer patients to psychiatrists if depression relapses. Those who prescribe a medicament all alone in most cases use sertraline, but even 38% of family doctors mention benzodiazepines. According to family doctors' answers, 32% of respondents re-evaluate the effect of medicaments in 4 weeks; on the other hand, 25% of them do not carry out such monitoring at all. The obtained results about the differences and efficiency of professional care question the quality of depression treatment in Lithuania. It is therefore necessary to formulate recommendations leading to corrections and rationalization of depression treatment.

Keywords: depression treatment; antidepressants; depression relapse

Received: May 18, 2011; Accepted: June 9, 2011; Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kavaliauskienė L, Pečiūra R, Adomaitienė V, Masteiková R. Improving the quality and cost-effectiveness of depression treatment. Čes. slov. farm. 2011;60(4):159-164.
Download citation

References

  1. Improving the Quality and Cost-Effectiveness of Treatment for Depression http://www.rand.org/pubs/research_briefs/RB4500-1/index1.html(2011.04.18)
  2. Data from the State Centre of Mental Health, http://www.vpsc.lt(2010.12.10)
  3. WHO Highlights on Health in Lithuania, March 2001, http://europa.eu.int/comm/health/ph_projects/1999/monitoring/lithuania_en.pdf
  4. Sobocki, P., Jönsson, B., Angst, J., Rehnberg, C.: Cost of depression in Europe. J. Mental Health Policy Econ. 2006; 9(2), 87-98.
  5. Neverauskas, J.: Ekonomiškai efektyvus depresijos gydymas [Cost-effective depression treatment]. Nervų ir psichikos ligos [Nervous and mental diseases], 2003; 1. http://www.medicine.lt/index.php?pagrid=leidiniai⊂id=npl&strid=128(2011.03.10).
  6. Kavaliauskienė, L., Pečiūra, R., Adomaitienė, V., Masteiková, R.: Depression relapse and antidepressants consumption in quality of life aspect. Čes. slov. Farm. 2010; 59, 199-204.
  7. Norkus, R., Macevičius, G.: Benzodiazepinų reikšmė gydant pacientus, sergančius depresija ir nerimo sutrikimais [Role of benzodiazepines in depression and anxiety disorders treatment]. Nervų ir psichikos ligos [Nervous and mental diseases], 2007; 6. http://www.medicine.lt/index.php?pagrid=leidiniai⊂id=npl&strid=7016(2010.08.15).
  8. Bobrow, R. S.: Benzodiazepines revisited. Family Practice 2003; 20, 347-349. Go to original source... Go to PubMed...
  9. Thase, M. E.: Achieving remission and managing relapse in depression. J Clin Psychiatry 2003; 64(Suppl 18), 3-7.
  10. Luppino, F., de Wit, L., Bouvy, P., Stijnen, T., Cuijpers, P., Penninx, B., Zitman, F.: Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010; 67(3), 220-229. Go to original source... Go to PubMed...
  11. Poynter, B., Shuman, M., Diaz-Granados, N., Kapral, M., Grace, S. L., Stewart, D. E.: Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics 2009; 50(6), 563-569. Go to original source... Go to PubMed...
  12. Mann, J. J.: The medical management of depression. N. Engl. J. Med. 2005; 353, 1819-1834. Go to original source... Go to PubMed...
  13. Recovery and relapse prevention. Centre for Addiction and Mental Health. http://www.camh.net/About_Addiction_Mental_Health/Mental_Health_Information/Depressive_Illness/dep_illness_relapse.html(2010.12.17).
  14. What is the general approach to treating depression? http://www.medicinenet.com/depression/page7.htm(2010.06.12).
  15. Lietuva pirmauja savižudybių skaičiumi regione [Lithuania is the first in suicide rates in region]. http://www.vtv.lt/naujienos/nusikaltimai/lietuva-pirmauja-savizudybiu-skaiciumi-regione.html(2010.06.10)




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.